Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization

BackgroundRadioembolization with yttrium-90 (Y-90) is utilized to treat primary liver malignancies. The efficacy of this intra-arterial therapy in arterially hypoperfused tumors is not known.MethodsWe reviewed data of patients with primary liver tumors treated with Y-90 prescription doses of at leas...

Повний опис

Бібліографічні деталі

Автори:	Bita Kalaghchi, Semra Ince, Justin Barnes, Kendall Kiser, Re-I Chin, Justin Mikell, Shahed Badiyan, Jose Garcia, Jacqueline Zoberi, Maria Bernadette Majella Doyle, Benjamin Tan, Seung Kim, Tyler Fraum, Hyun Kim
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-08-01
Серія:	Frontiers in Oncology
Предмети:	hepatocellular carcinoma Y-90 intra-arterial therapy hypoperfusion cholangiocarcinoma
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1433480/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!